• OPEN AN ACCOUNT
Indian Indices
Sensex
80,999.40 -28.62
( -0.04%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Poly Medicure Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
531768
INE205C01021
315.8720064
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
POLYMED
47.04
16192.49
EPS(TTM)
Face Value()
Div & Yield %
33.96
5
0.22
 

Nuvama Wealth Management board approves investment of up to Rs 700 cr in subsidiaries
Nov 06,2026
The board of Nuvama Wealth Management at its meeting held on 06 November 2026 has approved the following:

- investment of an amount not exceeding Rs. 400 crore, in one or more tranches, through subscription in the equity shares of Nuvama Wealth Finance (NWFL), a wholly owned material subsidiary of the Company.

- investment of an amount not exceeding Rs. 300 crore, in one or more tranches, through subscription in the equity shares of Nuvama Wealth and Investment (NWIL), a wholly owned material subsidiary of the Company.